Amino nicotinate derivatives as glucokinase (GLK) modulators
US7160906B2 · kind B2 · utility
0Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2002 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | Jun 24, 2022 |
Classification
- Technology area (CPC —)General
Abstract
The invention related to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, useful in the treatment of adisease or condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.